GPBAR1 and metabolic dysfunction-associated steatotic liver disease: Altered bile acid profiles are associated with worsened non-alcoholic fatty liver disease (NAFLD), IBD, and possibly PSC by disrupting the FXR and TGR5 anti-inflammatory balance.